The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics
Year: 2016
Type: review
DOI: 10.1200/edbk_159135
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: triple-negative breast cancer, molecular subtypes, basal-like breast cancer, claudin-low breast cancer, TP53 mutation, PI3K signaling, MEK pathway, BRCA pathway, platinum-based chemotherapy, PARP inhibitors, immunotherapy, PD-1 inhibitors, PD-L1 inhibitors, neoadjuvant therapy, pathological complete response, tumor immune infiltrate, metastatic breast cancer
Open Access status: closed
OpenAlex ID: W4239622015
